ClearVia new probiotic supports better metabolization of alcohol
NEW YORK — ClearVia, a probiotic that naturally supports the body's ability to metabolize alcohol, launched nationwide on Wednesday. A proprietary probiotic blend, ClearVia helps the body's natural ability to break down alcohol while sleeping so after a night of enjoying a few drinks busy professionals can wake up clear and ready to take on their day, the company stated.
"We designed ClearVia for the social drinker who has lots of responsibilities balancing work and family and can't afford to miss a beat," stated Mauro Pennella, president ClearVia Labs. "It's a great aid for the professional who often socializes with clients as part of their work."
ClearVia specifically works by providing support to the liver so it can better metabolize alcohol. The probiotic blend helps turn acetaldehyde, that is formed when the body incompletely metabolizes alcohol, into mild acetic acid (vinegar). The more acetaldehyde build up someone has in their body the worse off they will feel in the morning.
The single-use, fast-dissolving orange flavored packets can be taken with water. According to a recent Gallup poll, nearly two thirds of Americans drink alcohol. Most Americans who drink alcohol do so regularly, as 67% reported having had at least one drink in the past week; 32% of Americans reported they had between one and seven drinks in the past week.
As people age, their body becomes less efficient at metabolizing alcohol. The activity of the enzymes necessary to process acetaldehyde decreases, which means it spends more time hanging out in the body causing unpleasant feelings in the morning.
ClearVia is currently available on Amazon and directly from ClearVia.com starting in May. It's available for a suggested retail price of $14.99 for five single packets or $24.99 for 10 single packets. In addition, ClearVia is also available to be purchased in bulk of 50 single serve packets.
2017 considered one of longest- and latest-running flu seasons
ATLANTA — The 2016/2017 influenza season is still ongoing. According to the latest statistics from the Centers for Disease Control and Prevention, flu incidence is still tracking above the national baseline, making this year both the longest-running season and the latest-running season in recent memory.
Last week the CDC reported a weighted national percentage of visits for influenza-like illnessess of 2.6%, still well above the 2.2% national baseline that indicates the beginning and end of a season. While this year started a little later than years past, it has already run a 17-week course and is still tracking. By comparison, the 2014/2015 season extended for approximately 16 weeks from start to finish.
Last year, ILI was above the 2.2% national baseline for only 11 weeks during the season, cresting at 3.6%. This year, ILI incidence reached a high mark of 5.1%.
Standard Homeopathic recalls teething tablets
LOS ANGELES — Standard Homeopathic Company last week recalled all lots of Hyland's Baby Teething Tablets and Hyland's Baby Nighttime Teething Tablets sold in retail stores to the consumer level.
"It is important for you to know that all manufactured and sold teething medicines met the company’s safety limit tests and all tested product has been well within an established safety threshold," the company stated in an open letter to consumers. "We very much regret the concern and confusion you may be feeling in regards to these products. Over the past months, we have appreciated the words of support from many of you. We remain confident of the safety of Hyland’s medicines."
The Hyland's Baby Teething Tablets and Hyland's Baby Nighttime Teething Tablets were used to provide temporary relief of teething symptoms in children. The recall includes all products that retailers may have had in stock. Standard Homeopathic stopped making and shipping the medicines nationwide in October 2016. This recall ensures the removal of any possible remaining products that may be on store shelves.
No other Standard Homeopathic Company/Hyland's products are affected by this recall.
"We initiated this recall even after discontinuing production last fall because it is appropriate to do what our regulating agency has formally requested," stated J.P. Borneman, chairman and CEO of Standard Homeopathic Company. "We are committed to maintaining and earning the trust consumers have placed in Standard Homeopathic Company. We have worked for 114 years to build relationships with our consumers. We intend to preserve that tradition of trust."
Standard Homeopathic Company is notifying its distributors and retailers by mail and is arranging for the return of all recalled products. Consumers who have products which are being recalled should discard the product.